Skip to main content

What DaVita's Quarter ended Sep 30, 2026 10-Q says: 3 signals

DaVita filed its latest 10-Q with the SEC on Oct 29, 2026. It discusses compliance burden, cybersecurity incident and product launch.

Public (DVA)Hospitals and Health Care10,000+ employeesdavita.comLinkedIn

Get DaVita's live signals in Claude or ChatGPT, or by API

AskWhat changed at DaVita this week? Use Autobound signals for davita.com.
Filed
Oct 29, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
20

Source: Autobound Signal API · 32 signals tracked for DaVita · updated

10-Q · latest 10

What DaVita's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 3 signals

    SEC EDGAR
  2. 10-Q

    Filed · 7 signals

    SEC EDGAR

Earlier 10-Q filings

Showing 10 of 20 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

DaVita earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Launching long-term investments to replace scheduling and upgrade revenue operations tech.The company is actively replacing its scheduling system and upgrading its revenue operations technology as part of a long-term IT infrastructure investment. This creates a significant opportunity for vendors specializing in healthcare scheduling and Revenue Cycle Management (RCM) platforms.
Investing in long-term replacement of core scheduling and revenue operations systems.The company is actively making long-term investments to replace its scheduling system and upgrade its revenue operations technology, presenting a clear opportunity for enterprise software vendors in these domains.
Experiencing negative business impact from a recent cyber incident.A recent cyber incident caused lost patient admissions, negatively impacted revenue per treatment, and slowed down revenue cycle operations. This event creates a strong impetus for reviewing and investing in cybersecurity, business continuity, and operational resilience solutions.
Committing to long-term IT and clinical innovation to create sustainable value.The CEO framed technology and clinical innovation not as one-off projects, but as a long-term strategic commitment to strengthen the company's capabilities. This indicates a durable spending environment for vendors who can align with their goals of superior patient care and sustainable value.
Investing in data science and research to advance kidney care therapies.The company highlighted its DaVita Clinical Research (DCR) division, which leverages one of the largest patient data sources in the country. This focus on data-driven research and development signals a need for data science, analytics, and clinical trial support technologies.
Deployed $1.5 billion in share repurchases year-to-date, showing strong capital position.The company has spent $1.5 billion on share buybacks this year, demonstrating significant financial strength and available capital. While not direct operational spending, it indicates a healthy balance sheet and the capacity to fund major strategic investments.

Signal API · MCP

Track DaVita with the Signal API

One POST /v1/companies/enrich call with davita.com returns DaVita 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"davita.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about DaVita 10-Q

When did DaVita file its latest 10-Q?
DaVita filed its latest 10-Q (Quarter ended Sep 30, 2026) on Oct 29, 2026. The one before it was filed on Aug 4, 2026.
What did DaVita disclose in its latest 10-Q?
From the filing dated Oct 29, 2026: DaVita to Roll Out Expanded Hemodialysis Therapy to Eligible Patients in November
What did DaVita say on its recent earnings calls?
Q3 FY2025: Launching long-term investments to replace scheduling and upgrade revenue operations tech. (dated Oct 29, 2025).
Where can I read DaVita's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/927066/000092706626000134/dva-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →